Investigators assessed the impact of mask wearing on perception of health during the COVID-19 pandemic.
American Health Care Association says infections are largely the result of a high number of cases in the surrounding community.
Clinical trial results indicate that ciclesonide inhalation may be an effective early antiviral therapy for mild to moderate COVID-19.
Vaccine protection against SARS-CoV-2 infection declined; protection remained higher against hospitalization, death.
Company has said that a second dose, given two months after the first, increases the vaccine’s effectiveness.
Rates of biochemically verified cannabis use early in pregnancy increased by 25 percent during versus 15 months before the pandemic.
Risk particularly heightened in the six months following diagnosis.
SARS-CoV-2 infection rate and hospitalization rate 4.9 and 29.2 times higher for unvaccinated versus fully vaccinated persons.
A meta-analysis of COMPASS and VOYAGER compared low-dose rivaroxaban and aspirin vs aspirin alone across a broad spectrum of patients with PAD.
Variant has not taken extensive hold in the United States at this point, but NIAID is taking it ‘very seriously’.